Patricia Galvan

Patricia Galvan

UNVERIFIED PROFILE

Are you Patricia Galvan?   Register this Author

Register author
Patricia Galvan

Patricia Galvan

Publications by authors named "Patricia Galvan"

Are you Patricia Galvan?   Register this Author

31Publications

1422Reads

33Profile Views

HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.

Lancet Oncol 2017 04 24;18(4):545-554. Epub 2017 Feb 24.

Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30021-9DOI Listing
April 2017

Value of a gene signature assay in patients with early breast cancer and intermediate risk: a single institution retrospective study.

Curr Med Res Opin 2016 05 12;32(5):835-9. Epub 2016 Feb 12.

a Lille University , Centre Oscar Lambret, Breast Cancer Department , Lille , France ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2016.1146664DOI Listing
May 2016

Clinical implications of the intrinsic molecular subtypes of breast cancer.

Breast 2015 Nov 5;24 Suppl 2:S26-35. Epub 2015 Aug 5.

Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2015.07.008DOI Listing
November 2015

Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.

Mol Oncol 2015 Jun 31;9(6):1081-90. Epub 2015 Jan 31.

Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain; Breast Cancer Unit, Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528764PMC
June 2015

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer.

Sci Transl Med 2015 Apr;7(283):283ra51

Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aaa4442DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433148PMC
April 2015

The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.

Cell Rep 2014 Mar 6;6(6):1059-1072. Epub 2014 Mar 6.

Department of Developmental, Chemical, and Molecular Biology, Tufts University, 145 Harrison Avenue, Boston, MA 02111, USA; Molecular Oncology Research Institute, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2014.02.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011189PMC
March 2014

Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer.

Mol Oncol 2014 Feb 13;8(1):20-6. Epub 2013 Sep 13.

Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2013.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528507PMC
February 2014

Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity.

Sci Rep 2013 Dec 18;3:3544. Epub 2013 Dec 18.

1] Breast Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain [2] Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep03544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506566PMC
December 2013

Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.

PLoS One 2013 22;8(3):e59762. Epub 2013 Mar 22.

Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu and Fundació Sant Joan de Déu, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0059762PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606108PMC
September 2013

A three-gene expression signature model for risk stratification of patients with neuroblastoma.

Clin Cancer Res 2012 Apr 10;18(7):2012-23. Epub 2012 Feb 10.

Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Edificio Docente 4th Floor, 08950 Esplugues de Llobregat, Barcelona 08950, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240975PMC
April 2012

Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.

Pediatr Blood Cancer 2011 Jul 7;57(1):69-75. Epub 2011 Mar 7.

Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22813DOI Listing
July 2011